Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 0.695 Delayed Data As of Aug 18 |  +0.0081 / +1.19%Today’s Change | 0.41 Today|||52-Week Range 0.80 | +19.11% Year-to-Date |
The 3 analysts offering 12-month price forecasts for Arch Therapeutics Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 2.00. The median estimate represents a +331.65% increase from the last price of 0.70.
The current consensus among 3 polled investment analysts is to Buy stock in Arch Therapeutics Inc. This rating has held steady since August, when it was unchanged from a rating.Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.
